Jefferies Financial Group Inc. Recursion Pharmaceuticals, Inc. Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$9.13 - $15.52 $1.55 Million - $2.64 Million
-169,890 Reduced 94.38%
10,110 $100,000
Q4 2023

Feb 13, 2024
BUY
$5.09 - $10.79 $865,300 - $1.83 Million
170,000 Added 1700.0%
180,000 $1.77 Million
Q3 2023

Nov 14, 2023
BUY
$6.59 - $15.86 $65,900 - $158,600
10,000 New
10,000 $76,000

Others Institutions Holding RXRX

# of Institutions
286
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.41B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email